MEF-2D along with other isoforms were found to increase expression of TGF-β in HCC, resulting in the activation of the PI3K/AKT/MEF-2 signaling pathway which promoted the progression of metastasis and EMT in HCC [180]. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.